Experiment 68069
Worktypes
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ORAL |
| Organism | Piper methysticum (PIPERACEAE) |
| Citation | DE LEO,V: LA MARCA,A: LANZETTA,D: PALAZZI,S: TORRICELLI,M: FACCHINI,C: MORGANTE,G:. (2000). EVALUATION OF THE ASSOCIATION OF KAVA-KAVA EXTRACT AND HORMONE REPLACEMENT THERAPY IN THE TREATMENT OF ANXIETY IN POSTMENOPAUSE.. 52(6) |
| Amount utilized | |
| Compound isolated | |
| Disease | FORTY WOMEN IN PHYSIOLOGICAL OR SURGICAL MENOPAUSEFOR THE PAST 1 TO 12 YEARS WERE ENROLLED IN THE STUDY. PATIENTS IN PHYSIOLOGICAL MENOPAUSE WERE RANDOMLY ASSIGNED TO ONE OF THE FOLLOWING PROTOCOLS. TTS NATURAL ESTROGENS 50 UG/DAY WITH PROGESTIN AND KAVA-KAVA EXTRACT AT A DOSE OF 100 MG (HRT=K, NO.=13); TTS NATURAL ESTROGENS 50 UG/DAY WITH PROGESTIN AND A PLACEBO PRODUCT (HRT, NO.=9). PATIENTSIN SURGICAL MENOPAUSE WERE RANDOMLY ASSIGNED TO ONE OF THE FOLLOWING PROTOCOLS: TTS NATURAL ESTROGENS 50 UG/DAY AND KAVA-KAVA EXTRACT AT A DOSE OF 100 MG (ERT+K, NO.=11); TTS NATURAL ESTROGENS50 UG/DAY AND A PLACEBO PRODUCT (ERT, NO.=7). EACHTREATMENT CYCLE LASTED FOR 6 MONTHS. THE OUTCOME OF THE STUDY WAS TO EVALUATE CHANGES IN THE HAMA SCORE. RESULTS. A SIGNIFICANT REDUCTION IN THE HAMA SCORE WAS OBSERVED AFTER 3 AND 6 MONTHS' TREATMENT IN ALL FOUR GROUPS OF WOMEN STUDIED. THE GROUPS TREATED WITH THE THERAPEUTIC ASSOCIATION (HRT+K, ERT+K) SHOWED A GREATER REDUCTION. |
| Dose amount | 100.0 MG |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | DAY |
| Dose expression | DOSE |
| Extract | TYPE EXT NOT STATED |
| Gender | FEMALE |